- Home
- AIRT vs NVNO Comparison
AIRT vs NVNO Comparison
Compare AIRT & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- NVNO
- Stock Information
- Founded
- AIRT 1980
- NVNO 1987
- Country
- AIRT United States
- NVNO United States
- Employees
- AIRT N/A
- NVNO N/A
- Industry
- AIRT Air Freight/Delivery Services
- NVNO Medical/Dental Instruments
- Sector
- AIRT Consumer Discretionary
- NVNO Health Care
- Exchange
- AIRT Nasdaq
- NVNO Nasdaq
- Market Cap
- AIRT 53.2M
- NVNO 71.0M
- IPO Year
- AIRT N/A
- NVNO N/A
- Fundamental
- Price
- AIRT $21.80
- NVNO $3.99
- Analyst Decision
- AIRT
- NVNO
- Analyst Count
- AIRT 0
- NVNO 0
- Target Price
- AIRT N/A
- NVNO N/A
- AVG Volume (30 Days)
- AIRT 1.1K
- NVNO 140.4K
- Earning Date
- AIRT 06-27-2025
- NVNO 07-30-2025
- Dividend Yield
- AIRT N/A
- NVNO N/A
- EPS Growth
- AIRT N/A
- NVNO N/A
- EPS
- AIRT N/A
- NVNO N/A
- Revenue
- AIRT $291,850,000.00
- NVNO N/A
- Revenue This Year
- AIRT N/A
- NVNO N/A
- Revenue Next Year
- AIRT N/A
- NVNO N/A
- P/E Ratio
- AIRT N/A
- NVNO N/A
- Revenue Growth
- AIRT 1.75
- NVNO N/A
- 52 Week Low
- AIRT $14.56
- NVNO $2.03
- 52 Week High
- AIRT $30.60
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- AIRT 61.08
- NVNO 51.05
- Support Level
- AIRT $18.86
- NVNO $3.86
- Resistance Level
- AIRT $24.92
- NVNO $4.36
- Average True Range (ATR)
- AIRT 0.91
- NVNO 0.31
- MACD
- AIRT -0.03
- NVNO -0.05
- Stochastic Oscillator
- AIRT 65.92
- NVNO 14.94
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.